Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells

Mostafa I. Waly, Badreldin H. Ali, Intisar Al-Lawati, Abderrahim Nemmar

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Emodin (a rhubarb anthraquinone) has strong antioxidant and anticancer actions, and recent studies indicated that it reduces cellular oxidative stress induced by various insults and drugs. Cisplatin is an anticancer drug that is associated with nephrotoxicity and induces oxidative stress in cultured human kidney (HEK 293) cells. This study aimed to assess the in-vitro antioxidant properties of the emodin against cisplatin-induced oxidative stress in HEK 293 cells. Our study revealed that emodin acted as a potent free radical scavenger and provided nephroprotection against cisplatin-induced oxidative stress. Emodin as low as 0.5μm did not decrease cell viability and restored the cisplatin-induced glutathione depletion and total antioxidant capacity in a dose-dependent manner. Emodin augmented the cisplatin-induced inhibition of antioxidant enzymes (catalase, glutathione peroxidase, glutathione S-transferase, glutathione reductase and superoxide dismutase). These results suggest that emodin has the potential to be used as an adjunct therapeutic agent in patients receiving cisplatin treatment.

Original languageEnglish
Pages (from-to)626-630
Number of pages5
JournalJournal of Applied Toxicology
Volume33
Issue number7
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Emodin
Oxidative stress
HEK293 Cells
Cisplatin
Oxidative Stress
Kidney
Antioxidants
Rheum
Anthraquinones
Free Radical Scavengers
Glutathione Reductase
Proxy
Glutathione Peroxidase
Glutathione Transferase
Pharmaceutical Preparations
Catalase
Superoxide Dismutase
Glutathione
Cell Survival
Cells

Keywords

  • Antioxidants
  • Cisplatin
  • Emodin
  • Oxidative stress

ASJC Scopus subject areas

  • Toxicology

Cite this

Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells. / Waly, Mostafa I.; Ali, Badreldin H.; Al-Lawati, Intisar; Nemmar, Abderrahim.

In: Journal of Applied Toxicology, Vol. 33, No. 7, 07.2013, p. 626-630.

Research output: Contribution to journalArticle

@article{437d680f1be4492bb66518b032adca68,
title = "Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells",
abstract = "Emodin (a rhubarb anthraquinone) has strong antioxidant and anticancer actions, and recent studies indicated that it reduces cellular oxidative stress induced by various insults and drugs. Cisplatin is an anticancer drug that is associated with nephrotoxicity and induces oxidative stress in cultured human kidney (HEK 293) cells. This study aimed to assess the in-vitro antioxidant properties of the emodin against cisplatin-induced oxidative stress in HEK 293 cells. Our study revealed that emodin acted as a potent free radical scavenger and provided nephroprotection against cisplatin-induced oxidative stress. Emodin as low as 0.5μm did not decrease cell viability and restored the cisplatin-induced glutathione depletion and total antioxidant capacity in a dose-dependent manner. Emodin augmented the cisplatin-induced inhibition of antioxidant enzymes (catalase, glutathione peroxidase, glutathione S-transferase, glutathione reductase and superoxide dismutase). These results suggest that emodin has the potential to be used as an adjunct therapeutic agent in patients receiving cisplatin treatment.",
keywords = "Antioxidants, Cisplatin, Emodin, Oxidative stress",
author = "Waly, {Mostafa I.} and Ali, {Badreldin H.} and Intisar Al-Lawati and Abderrahim Nemmar",
year = "2013",
month = "7",
doi = "10.1002/jat.1788",
language = "English",
volume = "33",
pages = "626--630",
journal = "Journal of Applied Toxicology",
issn = "0260-437X",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells

AU - Waly, Mostafa I.

AU - Ali, Badreldin H.

AU - Al-Lawati, Intisar

AU - Nemmar, Abderrahim

PY - 2013/7

Y1 - 2013/7

N2 - Emodin (a rhubarb anthraquinone) has strong antioxidant and anticancer actions, and recent studies indicated that it reduces cellular oxidative stress induced by various insults and drugs. Cisplatin is an anticancer drug that is associated with nephrotoxicity and induces oxidative stress in cultured human kidney (HEK 293) cells. This study aimed to assess the in-vitro antioxidant properties of the emodin against cisplatin-induced oxidative stress in HEK 293 cells. Our study revealed that emodin acted as a potent free radical scavenger and provided nephroprotection against cisplatin-induced oxidative stress. Emodin as low as 0.5μm did not decrease cell viability and restored the cisplatin-induced glutathione depletion and total antioxidant capacity in a dose-dependent manner. Emodin augmented the cisplatin-induced inhibition of antioxidant enzymes (catalase, glutathione peroxidase, glutathione S-transferase, glutathione reductase and superoxide dismutase). These results suggest that emodin has the potential to be used as an adjunct therapeutic agent in patients receiving cisplatin treatment.

AB - Emodin (a rhubarb anthraquinone) has strong antioxidant and anticancer actions, and recent studies indicated that it reduces cellular oxidative stress induced by various insults and drugs. Cisplatin is an anticancer drug that is associated with nephrotoxicity and induces oxidative stress in cultured human kidney (HEK 293) cells. This study aimed to assess the in-vitro antioxidant properties of the emodin against cisplatin-induced oxidative stress in HEK 293 cells. Our study revealed that emodin acted as a potent free radical scavenger and provided nephroprotection against cisplatin-induced oxidative stress. Emodin as low as 0.5μm did not decrease cell viability and restored the cisplatin-induced glutathione depletion and total antioxidant capacity in a dose-dependent manner. Emodin augmented the cisplatin-induced inhibition of antioxidant enzymes (catalase, glutathione peroxidase, glutathione S-transferase, glutathione reductase and superoxide dismutase). These results suggest that emodin has the potential to be used as an adjunct therapeutic agent in patients receiving cisplatin treatment.

KW - Antioxidants

KW - Cisplatin

KW - Emodin

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84878209762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878209762&partnerID=8YFLogxK

U2 - 10.1002/jat.1788

DO - 10.1002/jat.1788

M3 - Article

VL - 33

SP - 626

EP - 630

JO - Journal of Applied Toxicology

JF - Journal of Applied Toxicology

SN - 0260-437X

IS - 7

ER -